These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 11106801)

  • 1. Role in tumorigenesis of silent mutations in the TP53 gene.
    Strauss BS
    Mutat Res; 2000 Dec; 457(1-2):93-104. PubMed ID: 11106801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silent and multiple mutations in p53 and the question of the hypermutability of tumors.
    Strauss BS
    Carcinogenesis; 1997 Aug; 18(8):1445-52. PubMed ID: 9276614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypermutability in carcinogenesis.
    Strauss BS
    Genetics; 1998 Apr; 148(4):1619-26. PubMed ID: 9560381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation and repeats in silent and nonsense mutations of p53.
    Kouidou S; Malousi A; Maglaveras N
    Mutat Res; 2006 Jul; 599(1-2):167-77. PubMed ID: 16620878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IARC p53 mutation database: a relational database to compile and analyze p53 mutations in human tumors and cell lines. International Agency for Research on Cancer.
    Hernandez-Boussard T; Rodriguez-Tome P; Montesano R; Hainaut P
    Hum Mutat; 1999; 14(1):1-8. PubMed ID: 10447253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
    Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
    Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 mutational pattern in Spanish and Polish non-small cell lung cancer patients: null mutations are associated with poor prognosis.
    de Anta JM; Jassem E; Rosell R; Martínez-Roca M; Jassem J; Martínez-López E; Monzó M; Sánchez-Hernández JJ; Moreno I; Sánchez-Céspedes M
    Oncogene; 1997 Dec; 15(24):2951-8. PubMed ID: 9416838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.
    Pollock PM; Pearson JV; Hayward NK
    Genes Chromosomes Cancer; 1996 Feb; 15(2):77-88. PubMed ID: 8834170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic review.
    Tornesello ML; Buonaguro L; Buonaguro FM
    Gynecol Oncol; 2013 Mar; 128(3):442-8. PubMed ID: 23168175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A specific spectrum of p53 mutations in lung cancer from smokers: review of mutations compiled in the IARC p53 database.
    Hernandez-Boussard TM; Hainaut P
    Environ Health Perspect; 1998 Jul; 106(7):385-91. PubMed ID: 9637795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 mutations in breast cancer.
    Coles C; Condie A; Chetty U; Steel CM; Evans HJ; Prosser J
    Cancer Res; 1992 Oct; 52(19):5291-8. PubMed ID: 1394133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid carcinoma is characterized by genomic instability: evidence from p53 mutations.
    Shahedian B; Shi Y; Zou M; Farid NR
    Mol Genet Metab; 2001 Feb; 72(2):155-63. PubMed ID: 11161841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P53 mutations associated with breast, colorectal, liver, lung, and ovarian cancers.
    Lasky T; Silbergeld E
    Environ Health Perspect; 1996 Dec; 104(12):1324-31. PubMed ID: 9118874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of p53 gene in gastric carcinoma in Taiwan.
    Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
    Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer.
    Berns EM; van Staveren IL; Look MP; Smid M; Klijn JG; Foekens JA
    Br J Cancer; 1998 Apr; 77(7):1130-6. PubMed ID: 9569050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of the p53 gene in human functional adrenal neoplasms.
    Lin SR; Lee YJ; Tsai JH
    J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Germline TP53 mutations and single nucleotide polymorphisms in children.
    Valva P; Becker P; Streitemberger P; Lombardi GM; Rey G; Guzman CA; Preciado MV
    Medicina (B Aires); 2009; 69(1 Pt 2):143-7. PubMed ID: 19414295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic studies of tumor suppressor gene regions on chromosomes 13 and 17 in colorectal tumors.
    Lothe RA; Fossli T; Danielsen HE; Stenwig AE; Nesland JM; Gallie B; Børresen AL
    J Natl Cancer Inst; 1992 Jul; 84(14):1100-8. PubMed ID: 1619684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 mutations in nonastrocytic human brain tumors.
    Ohgaki H; Eibl RH; Wiestler OD; Yasargil MG; Newcomb EW; Kleihues P
    Cancer Res; 1991 Nov; 51(22):6202-5. PubMed ID: 1933879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of TP53 gene mutations in sinonasal cancer.
    Holmila R; Bornholdt J; Suitiala T; Cyr D; Dictor M; Steiniche T; Wolff H; Wallin H; Luce D; Husgafvel-Pursiainen K
    Mutat Res; 2010 Apr; 686(1-2):9-14. PubMed ID: 20025891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.